Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide-based transplant.

Blood Adv · 2023 · PMC10698256 · PMID 37906513

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

5 All-cause mortality at week 24 was reduced in recipients of letermovir; however, this reduction did not reach statistical significance at week 48 after allo-HCT.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.